Half-year report · HY
286A.TEDINET S100YWR5
Period2026-01-01 → 2026-06-30
Filed2026-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥24.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥395m | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥361m | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥981m | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥256m | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥489m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥824m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥560m | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥887m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥67.5bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥65.1bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥61.2bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.2bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.3bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.3bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥21.8bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.7bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.9bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.1bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥551m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥92m | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.3bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥856m | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥13.67 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.07 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.2 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥13.57 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥76.75 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.75 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.2% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.3% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2026-01-01 → 2026-06-30 | ¥376m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2026-01-01 → 2026-06-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥16m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥731m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥5.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥5.0bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥15m |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥457m |
| Elderly Care Related Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.4bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥740,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥312m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.8bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥240m |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.3bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2026-01-01 → 2026-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥16m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2026-01-01 → 2026-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-01-01 → 2025-06-30 | ¥219m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-06-30 | ¥41m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥640,000 |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥670m |
| Comprehensive Medical Management Support Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.1bn |
| Comprehensive Medical Management Support Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥395,000 |
| Comprehensive Medical Management Support Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.3bn |
| Elderly Care Related Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.7bn |
| Elderly Care Related Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥245,000 |
| Elderly Care Related Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥187m |
| Specially Controlled Medical Device Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.6bn |
| Specially Controlled Medical Device Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥276m |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.3bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥10.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥640,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 552
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss | Prior1InterimDuration | 887447000 | JPY |
| Profit loss | InterimDuration | 560310000 | JPY |
| Profit loss attributable to non controlling interests | Prior1InterimDuration | 63835000 | JPY |
| Profit loss attributable to non controlling interests | InterimDuration | 71051000 | JPY |
| Profit loss attributable to owners of parent | Prior1InterimDuration | 823612000 | JPY |
| Profit loss attributable to owners of parent | InterimDuration | 489258000 | JPY |
| Profit loss | Prior1InterimDuration | 887447000 | JPY |
| Profit loss | InterimDuration | 560310000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1InterimDuration | -640000 | JPY |
| Valuation difference on available for sale securities net of tax oci | InterimDuration | -952000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1InterimDuration | -113473000 | JPY |
| Deferred gains or losses on hedges net of tax oci | InterimDuration | -35980000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1InterimDuration | -2807000 | JPY |
| Foreign currency translation adjustment net of tax oci | InterimDuration | -2493000 | JPY |
| Other comprehensive income | Prior1InterimDuration | -116920000 | JPY |
| Other comprehensive income | InterimDuration | -39426000 | JPY |
| Comprehensive income | Prior1InterimDuration | 770526000 | JPY |
| Comprehensive income | InterimDuration | 520883000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1InterimDuration | 750937000 | JPY |
| Comprehensive income attributable to owners of the parent | InterimDuration | 463712000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1InterimDuration | 19589000 | JPY |
| Comprehensive income attributable to non controlling interests | InterimDuration | 57170000 | JPY |
| Income before income taxes | Prior1InterimDuration | 1215910000 | JPY |
| Income before income taxes | InterimDuration | 256461000 | JPY |
| Depreciation and amortization ope cf | Prior1InterimDuration | 469745000 | JPY |
| Depreciation and amortization ope cf | InterimDuration | 485442000 | JPY |
| Amortization of goodwill ope cf | Prior1InterimDuration | 75552000 | JPY |
| Amortization of goodwill ope cf | InterimDuration | 150664000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1InterimDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | InterimDuration | -28901000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1InterimDuration | -173000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | InterimDuration | -486000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1InterimDuration | -82534000 | JPY |
| Increase decrease in provision for bonuses ope cf | InterimDuration | -120040000 | JPY |
| Interest and dividends income ope cf | Prior1InterimDuration | -15634000 | JPY |
| Interest and dividends income ope cf | InterimDuration | -17772000 | JPY |
| Interest expenses ope cf | Prior1InterimDuration | 297731000 | JPY |
| Interest expenses ope cf | InterimDuration | 345038000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1InterimDuration | -111103000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | InterimDuration | -4228000 | JPY |
| Loss on retirement of noncurrent assets ope cf | Prior1InterimDuration | － | JPY |
| Loss on retirement of noncurrent assets ope cf | InterimDuration | 29672000 | JPY |
| Gain on forgiveness of debt ope cf | Prior1InterimDuration | -138172000 | JPY |
| Gain on forgiveness of debt ope cf | InterimDuration | － | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1InterimDuration | -30948000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | InterimDuration | 1342926000 | JPY |
| Decrease increase in inventories ope cf | Prior1InterimDuration | -97460000 | JPY |
| Decrease increase in inventories ope cf | InterimDuration | -683883000 | JPY |
| Decrease increase in operating loans receivable ope cf | Prior1InterimDuration | -861683000 | JPY |
| Decrease increase in operating loans receivable ope cf | InterimDuration | -851953000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |